A Rutgers study has found that a specific gene in cancerous prostate tumors indicates when patients are at high-risk for the cancer to spread, suggesting that targeting this gene can help patients live longer. The study, which was published in the journal Nature Communications, identified the NSD2 gene through a computer algorithm developed to determine […]Continue Reading ...
A new study confirms the long-suspected role of obesity as a risk factor for developing renal cell carcinoma (RCC), a type of kidney cancer, and identifies several specific obesity-related factors. These factors include multiple measures of obesity, diastolic blood pressure and fasting insulin. In contrast, the study found little evidence for an association with RCC […]Continue Reading ...
Jan 18 2019 Payer reimbursement requirements, uncertainties in reform policy, and cost of new treatments viewed as top threats At a time of unprecedented advances in the science of cancer, growing complexity in cancer treatments, and ongoing health policy fluctuation, the Association of Community Cancer Centers (ACCC) ninth annual Trending Now in Cancer Care survey […]Continue Reading ...
A study by researchers at University of Colorado Cancer Center and Oregon Health & Science University published today in the Journal of the American Medical Association Network shows that breast cancers diagnosed in young women within 10 years of giving birth are more likely to metastasize, and thus more likely to cause death, than breast […]Continue Reading ...
A multicenter study from SWOG Cancer Research Network found that infections with hepatitis B and C are common in new cancer patients, but few of these patients are screened for the viruses.Continue Reading ...
Cancers most commonly arise because of a series of two to five mutations in different genes that combine to cause a tumor. Evidence from a growing number of experiments focused on truncal mutations–the first mutations in a given sequence–suggests a new direction in understanding the origins of cancer. In a paper published today in Cancer […]Continue Reading ...
Researchers at the University of Toronto have discovered mutational signatures of tumor hypoxia (low oxygen) in 19 cancer types. The results could be used to help clinicians identify patients who would benefit from higher treatment doses. m63085 | Shutterstock In a landmark pan-cancer study analyzing more than 8,000 tumors across 19 different cancer types, researchers […]Continue Reading ...
Skin cancer is on the rise in the United States. Squamous cell carcinoma, the second most common form of cancer in the U.S., has the highest mortality rate of all non-melanoma skin cancers. In roughly two to five percent of patients, the disease will metastasize and spread throughout the body, making it difficult to treat. […]Continue Reading ...
Credit: CC0 Public Domain In a new study, Yale Cancer Center (YCC) scientists suggest that as the number of clinical trials in cancer immunotherapy grows exponentially, some caution should be exercised as we continue to better understand the biology of these new therapeutic targets. The findings are published today in the journal Cell. Researchers around […]Continue Reading ...
A team of scientists from the National University of Science and Technology “MISIS”, the Moscow Technological University (MIREA) and the Pirogov Russian National Research Medical University has experimentally proved the effectiveness of the formerly suggested “light” method in oncotherapy. In a series of laboratory preclinical tests, the tumor growth stopped in 70% of mice, treated […]Continue Reading ...
A population health study from IUPUI and the Regenstrief Institute has identified striking socioeconomic and racial disparities in health behavior and in the receipt of cancer screening in the 34 Indiana counties with cancer death rates higher than the state’s average. Overall, the state of Indiana ranks high — 11th nationally — in cancer deaths. […]Continue Reading ...
A new report published today in JAMA Oncology describes alarmingly high rates of undiagnosed acute and chronic hepatitis B and hepatitis C in patients with cancer. These diseases could be seriously detrimental to treatment outcomes. vitstudio | Shutterstock Hepatitis B and hepatitis C are serious but treatable viral infections, which can have life-threatening complications. These […]Continue Reading ...
In the first effort to predict the future burden of colorectal cancer mortality globally, researchers note that colon and rectal cancer mortality rates are projected to decrease in most countries apart from some Latin American and Caribbean countries, but increases are predicted for several countries from Europe, North America and Oceania. The findings are published […]Continue Reading ...
A new study from a Massachusetts General Hospital (MGH) research team has found that the hypertension drug losartan, which targets the angiotensin signaling pathway, may improve the effectiveness of chemotherapy agents used to treat ovarian cancer. Previous research from the same team identified a similar effect for losartan in animal models of breast and pancreatic […]Continue Reading ...
Jan 16 2019 As cancer cells respond to cues in their microenvironment, they can enter a highly plastic state in which they are susceptible to transdifferentiation into a different type of cell. Researchers at the University of Basel in Switzerland exploited this critical phase, known as an epithelial-mesenchymal transition (EMT), to coax breast cancer cells […]Continue Reading ...
- 4.6 percent of Massachusetts residents have opioid use disorder
- New study suggests vital exhaustion as risk factor for dementia
- New antibiotic discovery heralds breakthrough in the fight against drug-resistant bacteria
- Ural Federal University scientists synthesize a group of multi-purpose fluorophores
- Researchers identify new therapeutic target in the fight against chronic liver diseases
- Preparation, characterization of Soyasapogenol B loaded onto functionalized MWCNTs
- FDA Approves Ontruzant (trastuzumab-dttb), a Biosimilar to Herceptin
- Tobacco use linked with higher use of opioids and sedatives
- Study delves deeper into developmental dyslexia
- Anti-vaccination movement one of the top health threats in 2019 says WHO
- Newly developed risk score more effective at identifying type 1 diabetes
- Highly effective protocol to prepare cannabis samples for THC/CBD analysis
- Prinston Pharmaceutical Inc. Issues Voluntary Nationwide Recall of Irbesartan and Irbesartan HCTZ Tablets Due to Detection of a Trace Amount of Unexpected Impurity, N-Nitrosodiethylamine (NDEA) in the Products
- How does solid stress from brain tumors cause neuronal loss, neurologic dysfunction?
- $14.7 million partnership to supercharge vaccine development
- Ian Fotheringham receives Charles Tennant Memorial Lecture award
- Brain vital signs detect neurophysiological impairments in players with concussions
- Lack of job and poor housing conditions increased likelihood of people attending A&E
- Novel targeted drug delivery system improves conventional cancer treatments
- Rutgers study finds gene responsible for spread of prostate cancer